Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid Boosting Tranexamic Acid Microneedling in Melasma
NCT05909072Phase 2Unknown
- Sponsor
- Zagazig University
- Start
- Jun 2023
- Primary completion
- Nov 2023
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of hyaluronic acid in melasma, sponsored by Zagazig University. Status: unknown.
02
Drugs
hyaluronic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT05909072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05909072.